Date published: 2026-6-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

WP631 methanesulfonate

0.0(0)
Write a reviewAsk a question

See product citations (1)

Application:
WP631 methanesulfonate is a fluorescent bisintercalating anthracycline antibiotic
Purity:
≥97%
Molecular Weight:
1349.38
Molecular Formula:
C62H64N2O202(CH4SO3)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

WP631 methanesulfonate is a chemical compound that may be of interest in various fields such as chemistry and materials science. As a methanesulfonate salt, it likely exhibits properties that make it soluble in certain solvents, which can be beneficial for its handling and application. In industrial or research applications, methanesulfonate salts are often used for their ability to act as intermediates in chemical synthesis. They can be involved in processes such as alkylation reactions, where they can transfer an alkyl group to another molecule. Additionally, they might be utilized as catalysts or reagents in specific types of organic reactions due to their acidic nature and ability to donate the methanesulfonate group. Moreover, in the context of materials science, WP631 methanesulfonate could have potential roles in the modification of surface properties or in the development of novel materials with specific features, such as enhanced conductivity or stability.


WP631 methanesulfonate References

  1. Systematic discovery of multicomponent therapeutics.  |  Borisy, AA., et al. 2003. Proc Natl Acad Sci U S A. 100: 7977-82. PMID: 12799470
  2. A novel and simple method of screening compounds for interaction with DNA: A validation study.  |  Garas, A., et al. 2009. Mutat Res. 678: 20-9. PMID: 19559098
  3. Sequential activation of hypoxia-inducible factor 1 and specificity protein 1 is required for hypoxia-induced transcriptional stimulation of Abcc8.  |  Woo, SK., et al. 2012. J Cereb Blood Flow Metab. 32: 525-36. PMID: 22086197
  4. Radiation damage and radioprotectants: new concepts in the era of molecular medicine.  |  Koukourakis, MI. 2012. Br J Radiol. 85: 313-30. PMID: 22294702
  5. Sp1 transcription factor interaction with accumulated prelamin a impairs adipose lineage differentiation in human mesenchymal stem cells: essential role of sp1 in the integrity of lipid vesicles.  |  Ruiz de Eguino, G., et al. 2012. Stem Cells Transl Med. 1: 309-21. PMID: 23197810
  6. Control of Fiat (factor inhibiting ATF4-mediated transcription) expression by Sp family transcription factors in osteoblasts.  |  Hekmatnejad, B., et al. 2013. J Cell Biochem. 114: 1863-70. PMID: 23463631
  7. Regulation of the Mechanism of TWIST1 Transcription by BHLHE40 and BHLHE41 in Cancer Cells.  |  Asanoma, K., et al. 2015. Mol Cell Biol. 35: 4096-109. PMID: 26391953
  8. Two drugs are better than one. A short history of combined therapy of ovarian cancer.  |  Bukowska, B., et al. 2015. Contemp Oncol (Pozn). 19: 350-3. PMID: 26793017
  9. Pulmonary toxicity generated from radiotherapeutic treatment of thoracic malignancies.  |  Deng, G., et al. 2017. Oncol Lett. 14: 501-511. PMID: 28693198

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

WP631 methanesulfonate, 200 µg

sc-301978
200 µg
$164.00

WP631 methanesulfonate, 500 µg

sc-301978A
500 µg
$398.00